Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Hideto Yamada; Masashi Deguchi; Shigeru Saito; Toshiyuki Takeshita

doi:10.1016/j.eclinm.2022.101617

Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Hideto Yamada^*, Masashi Deguchi, Shigeru Saito, Toshiyuki Takeshita

^*Corresponding author for this work

Member of the Board

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Article number	101617
Journal	eClinicalMedicine
Volume	52
DOIs	https://doi.org/10.1016/j.eclinm.2022.101617
State	Published - 2022/10

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.eclinm.2022.101617

Cite this

@article{15e6a85079494b019f53f28edb517dd6,

title = "Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial",

author = "Hideto Yamada and Masashi Deguchi and Shigeru Saito and Toshiyuki Takeshita",

year = "2022",

month = oct,

doi = "10.1016/j.eclinm.2022.101617",

language = "英語",

volume = "52",

journal = "eClinicalMedicine",

issn = "2589-5370",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses

T2 - A double-blind, randomised, placebo-controlled trial

AU - Yamada, Hideto

AU - Deguchi, Masashi

AU - Saito, Shigeru

AU - Takeshita, Toshiyuki

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85136566182&partnerID=8YFLogxK

U2 - 10.1016/j.eclinm.2022.101617

DO - 10.1016/j.eclinm.2022.101617

M3 - Letter

C2 - 36065419

AN - SCOPUS:85136566182

SN - 2589-5370

VL - 52

JO - eClinicalMedicine

JF - eClinicalMedicine

M1 - 101617

ER -